Related by context. All words. (Click for frequent words.) 73 Alpha Tocopherol Beta Carotene 68 Prostate Cancer Prevention 66 Ovarian Cancer Screening 65 Spine Patient Outcomes 64 Evaluation WISE 63 Intervention Trial 63 GISSI 62 Prostate Lung Colorectal 62 Ocular Hypertension Treatment 61 Cardiovascular Risk 61 Osteoporotic Fractures 61 prospective multicentre 61 NICE SUGAR 61 Aggressive Reduction 61 CALERIE 61 Multicentre 60 Women Ischemia Syndrome 60 Intervention Trial GAIT 60 ECASS 60 PLCO 60 Multicenter Study 60 HYVET 60 multicenter randomized controlled 59 multicenter randomized clinical 59 Intervention Effectiveness CATIE 59 Digital Mammographic Imaging 59 Lung Cancer Screening 59 Asthma Intervention 59 Stenting Trial CREST 59 STEP BD 59 Multicenter 59 Nonalcoholic Fatty Liver Disease 59 longitudinal cohort study 59 Multicenter Automatic Defibrillator Implantation 58 Glucosamine Chondroitin Arthritis 58 ONTARGET 58 EURIDIS 58 Intervention Effectiveness 57 Cardiovascular Risk Factors 57 ABCSG 57 Securitate Archives CNSAS 57 Controlled Trial 57 Carotid Revascularization Endarterectomy vs. 57 Ovarian PLCO Cancer 56 ERSPC 56 Therapeutic Effects 56 Hematological 56 Current Controlled Trials 56 randomized blinded placebo 56 BCIRG 56 Arimidex Tamoxifen Alone 56 NCCTG N# 56 LUX Lung 56 multicentre randomized 56 Scandinavian Simvastatin Survival 56 CLARITY TIMI 56 multicentre prospective 56 Prostate Cancer Screening 56 Gynecologic Oncology Group 56 subanalysis 56 Acetonide 56 Screening Trial 56 Insulin Resistance Atherosclerosis 56 ExTRACT TIMI 56 retrospective cohort 56 Randomized Evaluation 55 prospective longitudinal 55 Male Ageing 55 placebo controlled clinical 55 Multicenter Phase 55 STRIDE PD 55 Diabetes Complications 55 Surgical Treatment 55 Randomized controlled 55 ACCORD Lipid 55 TG MV 55 Cholesterol Levels SPARCL 55 placebo controlled Phase III 55 RE LY ® 55 phase IIIb 55 Gastric Cancer 55 Trial NLST 55 INTERHEART study 55 WHEL 55 Multicenter AIDS 55 ELCAP 55 Clinical Antipsychotic Trials 55 HPTN 55 Nord Trøndelag Health 55 Birth Cohort 54 Risk Behavior 54 Meta analyzes 54 ACRIN 54 Therapeutic Arthritis 54 Etiology 54 Trandolapril 54 Acute Stroke 54 Multiethnic Study 54 Severe Asthma 54 cerebral microbleeds 54 LUMINATE 54 Left Ventricular Dysfunction 54 Lancet Oncology journal 54 Glucosamine chondroitin Arthritis 54 Neoplasia 54 PROactive study 54 SWOG 54 Sexual Victimization 54 Prospective Multicenter 54 Hepatotoxicity 54 prostate cancer CaP 54 Dubbo Osteoporosis Epidemiology 54 randomized multicenter 54 Screening Trial DMIST 54 BERKELEY CA UroToday.com 54 RIO Lipids 54 ADMIRE HF 54 Malignant Melanoma 54 Randomised 54 REACH Registry 54 CAMMS# 54 Prostate Cancer ERSPC 54 cluster randomized controlled 54 prospective observational 54 Adenomas 54 Meta Analysis 54 retrospective cohort study 54 CARE HF 54 BARI 2D 54 VADT 54 Cancer Incidence 54 Perinatal Mortality 53 Multicenter Trial 53 Interpersonal Psychotherapy 53 CAPRIE 53 Cardiovascular Outcomes 53 Biological Effects 53 Chronic Heart Failure 53 ENESTnd 53 Stroke Prevention 53 CARDIA 53 substudy 53 longitudinal observational study 53 ACTIVE W 53 PRoFESS 53 AIDS Clinical Trials 53 ARBITER 6 53 Infarct 53 Atherosclerosis MESA 53 Prospective Randomized 53 Clinical Evaluation 53 Prostate Disease 53 Canadian Multicentre Osteoporosis 53 Acute Myocardial Infarction 53 Acute Coronary Syndromes 53 Clinical Outcome 53 Nicotine Addiction 53 CALGB 53 Radiation Therapy Oncology 53 SPARCL 53 Lp PLA 2 53 multicentre 53 Lipid Lowering Treatment 53 Antiepileptic Drugs 53 BRIM3 53 Postmenopausal 53 BJU International 53 multicenter phase 53 NSABP B 53 CAPRISA 53 Stent Thrombosis 53 prospective observational cohort 53 liver transplant recipients 53 Celecoxib APC trial 53 Placebo controlled 53 Ranolazine 53 Echocardiographic 53 Cognitive Impairment 53 Investigator Initiated 53 Ischemic Stroke 53 Neuroepidemiology 53 Preliminary Findings 52 Health Initiative Observational 52 SORT OUT III 52 AIM HIGH 52 spontaneous preterm delivery 52 observational cohort 52 INTERPHONE 52 UKPDS 52 Psychiatric Morbidity 52 multicentre randomized controlled 52 INTERMAP 52 Coronary Heart Disease 52 MADIT II 52 Male Infertility 52 AVERROES 52 PREVENT IV 52 Subgroup analysis 52 ASSERT 52 Thrombolysis 52 Framingham Offspring Study 52 Prostate Cancer Outcomes 52 Randomized Controlled Trials 52 Serious Adverse Events 52 EAT Eating 52 Cardiac Allograft Rejection 52 HF ACTION 52 iPrEx study 52 REALITY Trial 52 Breast Cancer Screening 52 COPERNICUS 52 Venous Thromboembolism 52 GYTS 52 EFNS 52 Hepatocellular Carcinoma 52 Randomized Study 52 ISEL 52 ALLHAT 52 symptomatic BPH 52 HCV SPRINT 52 Breast Carcinoma 52 Gore REDUCE Clinical 52 HeFT 52 Cochrane Systematic Review 52 Stenting Trial 52 Sequenced Treatment Alternatives 52 Myocardial Ischemia 52 Lung Injury 52 Urgent Intervention Triage 52 ADHERE 52 Postmenopausal Hormone Therapy 52 Patient Registry 52 Nutritional Status 52 Edge STudy 52 Cellular Immunotherapy 52 Nicotine Dependence 52 observational cohort study 52 JAK Inhibitor 52 Treatment Outcome 52 Efficacy Study 52 Phase Ib clinical 52 prospective randomized multicenter 52 Diabetologia 52 multicenter prospective 52 multicenter placebo controlled 52 Cancer Genetic Markers 52 Dietary Modification Trial 52 Ischemic 51 PRE SURGE 51 EORTC 51 PROactive 51 Epidemiologic 51 Neoplasms 51 Young Adults CARDIA 51 Patient Outcomes 51 prospective randomized placebo 51 Ischemic Heart Disease 51 CATIE AD 51 NESARC 51 TRITON TIMI 51 Early Lung Cancer 51 Phase IIIb 51 ACCORD Eye 51 Invasive Breast Cancer 51 Prospective Randomized Trial 51 STICH trial 51 Non Insulin Dependent 51 prospective multicenter 51 Observational Study 51 landmark ATHENA 51 Insulin Sensitivity 51 Pharmacokinetic PK 51 Complications Trial 51 EchoCRT 51 glucocorticoid induced osteoporosis 51 Randomized Clinical Trial 51 Cognitive Functioning 51 Carotid Endarterectomy 51 iPrEx 51 Pregnancy Outcome 51 Contraceptive Use 51 Trial PCPT 51 Molecular Basis 51 randomized controlled clinical 51 Randomised Study 51 Inflammatory Markers 51 PFO migraine 51 prospective nonrandomized 51 Urologic Cancer 51 Hemorrhagic Stroke 51 Lifestyle Intervention 51 Oral Fingolimod 51 postmenopausal hormone therapy 51 Alzheimer Disease Genetics 51 multicentre randomized double 51 Microbicide 51 Refractory Angina 51 Overactive Bladder 51 atrophic gastritis 51 MADIT 51 selenium supplementation 50 BOLDER II 50 Prostate AdenoCarcinoma Treatment 50 SCD HeFT 50 Phase III randomized 50 NeuroImage 50 Birth Defects Prevention 50 Cerebral Cortex 50 Acute Decompensated Heart Failure 50 Chicago Multidisciplinary Symposium 50 Induced Abortion 50 Anthropometric 50 TMC# C# 50 Coronary Revascularization 50 Polyp Prevention Trial 50 HIV seronegative 50 CALGB # [001] 50 Childhood Asthma 50 Phase IIA 50 prospective observational studies 50 T1DM 50 Nymox NX 50 multicentre study 50 Sexual Function 50 AREDS 50 Systolic Hypertension 50 Adverse Event 50 Cardiovascular Risk Reduction 50 Adjuvant Breast Cancer 50 ACCOMPLISH 50 Breast Density 50 Carotid Stenting 50 BMC Neuroscience 50 conducted retrospective cohort 50 randomized controlled trials RCTs 50 Sociodemographic 50 undergone radical prostatectomy 50 double blinded randomized 50 Clinical Practice Guidelines 50 Cardiovascular Mortality 50 GISSI HF 50 Vertos II 50 RE LY 50 Neurotoxicology 50 European Randomized Study 50 Illicit Drug Use 50 dysglycemia 50 Acute Liver Failure 50 EMPHASIS HF 50 CRN Sourcing 50 randomized Phase IIb 50 #:#-# [037] 50 psychiatric morbidity 50 atherothrombotic disease 50 Stop Hypertension DASH 50 J Clin Oncol 50 Uterine Fibroid 50 Eye Diseases 50 Afatinib 50 Pharmacologic 50 Insulin Resistance 50 #:#-# [035] 50 chromium supplementation 50 Pooled Analysis 50 Urinary Incontinence 50 Intensive Care Medicine 50 Chronic Lyme Disease 50 Cardiotoxicity 50 Study ADCS 50 Vasogen Celacade 50 randomized Phase III 50 Phytotherapy Research 50 Cohort Study 50 NCT# ClinicalTrials.gov 50 HCV RESPOND 2 50 prospective multicenter study 50 nonpregnant women 50 randomized multicentre 50 PreCISe 50 Treating Chronic 50 EVEREST II 50 Acta Paediatrica 49 prospective cohort 49 Systematic Review 49 MERLIN TIMI 49 CT Colonography Trial 49 systolic hypertension 49 Neuroprotection 49 Diabetes Interventions 49 meta regression 49 logistic regression analyzes 49 Risk Stratification 49 CHAMPION PCI 49 Female Genital Cutting 49 ASTEROID 49 serum lipid levels 49 Cytogenetic 49 Platelet Inhibition 49 CUSTOM II 49 Nephrology Dialysis Transplantation 49 Restless Legs 49 Overactive Bladder OAB 49 Antihypertensive 49 Bone Mineral Density 49 Karolinska Institute Sweden 49 depressive symptomatology 49 Sexual Dysfunction 49 subclinical hypothyroidism 49 Gynecological Cancer 49 Systematic Treatment 49 Cornea Donor Study 49 Treat Parkinson Disease 49 Phase III AFFIRM 49 dyslipidaemia 49 Psychiatric Disorders 49 multicenter randomized 49 strontium ranelate 49 Inflammatory Bowel Diseases 49 Myocardial Infarction 49 pharmacokinetic interaction 49 ESHO 49 Clinical Practice Guideline 49 Alcohol Consumption 49 Cephalalgia 49 International Verapamil SR 49 Alcohol Dependence 49 candesartan 49 Non Alcoholic Steatohepatitis 49 Benign Prostatic Hyperplasia 49 premature ejaculation PE 49 Observational Studies 49 PLOS 49 Kidney Transplantation 49 multicentric 49 DAPT 49 Multi Ethnic Study 49 Arteriosclerosis 49 Mortality Risk 49 ACUITY trial 49 colorectal cancer incidence 49 Phase IIIb clinical 49 suicide attempters 49 ILLUSTRATE 49 Gynecologic Cancer 49 atherogenic dyslipidemia 49 Prospective Cohort Study 49 INTERHEART 49 Climatic Changes 49 RTOG 49 Severe Sepsis 49 abacavir Ziagen 49 Genital Herpes 49 testosterone supplementation 49 ESPAD 49 Suicidal Behavior 49 Cognitive Function 49 National Epidemiologic Survey 49 journal Ophthalmology 49 Abdominal Obesity 49 PCa 49 Thromboembolism 49 MAPT 49 NSABP 49 COMBINE Study 49 RE LY trial 49 Telmisartan 49 Wisconsin Sleep Cohort 49 MetS 49 RE MODEL 49 CLL8 49 DBMD 49 prostate carcinogenesis 49 polyarticular 49 CURRENT OASIS 7 49 riociguat 49 TOHP 49 EUROCARE 49 Randomized Phase 49 bivariate analyzes 49 gallstone disease 49 SNCA 49 Genetic Variation 49 APEX AMI trial 49 BOLDER 49 Related Mortality 49 Pregnancy Outcomes 49 Combination Treatment 48 Sudden Cardiac Death 48 Hemodialysis Patients 48 carotid artery stenting CAS 48 AA Amyloidosis 48 Decompensated Heart Failure 48 Swedish Mammography Cohort 48 Injury Mortality 48 ENDEAVOR III 48 Nutrition Examination 48 subclinical atherosclerosis 48 Sexual Behaviors 48 Lumbar Spine 48 Colorectal 48 Preclinical Models 48 PERSEUS 48 mammographic density 48 multicenter randomized double 48 UroToday.com 48 PON1 activity 48 Phase IIB 48 WHIMS 48 MEND CABG 48 FACIT 48 AIR2 Trial 48 Randomised Controlled Trial 48 blinded randomized 48 randomized crossover 48 Morbidity Mortality 48 carotid IMT 48 Preterm Birth 48 serum folate concentrations 48 Genetic Markers 48 Communities ARIC Study 48 EquiTrend ® 48 Uterine Cancer 48 B Cell Lymphoma 48 nulliparous women 48 cinacalcet 48 Phase Ib II 48 generalizability 48 SF #v# 48 Randomized 48 Relieve Depression 48 Coronary Artery Calcium 48 HIVNET 48 macrovascular disease 48 Randomized Phase II 48 Adiposity 48 Septic Shock 48 OPT CHF 48 Main Outcome Measure 48 NCIC Clinical Trials 48 Prognostic Factors 48 multicenter randomized placebo controlled 48 randomized blinded 48 Relieve Depression STAR 48 Anticancer Drug 48 HIV HCV coinfected 48 multicenter study 48 ASCO GU 48 Pharmacodynamic 48 BR.# 48 Therapeutic Intervention 48 Partnership Attitude Tracking 48 PROactive Study 48 Phase III randomized placebo 48 Comorbidity 48 cilostazol 48 Genotypes 48 psychiatric outpatients 48 Subgroup Analysis 48 Chemoprevention 48 Arch Intern Med 48 Psychological Stress 48 Interphone Study 48 folate supplementation 48 Glioma 48 ADAGIO 48 Fibroid 48 Coronary Artery Risk 48 Aggressive Behavior 48 journal Rheumatology 48 FOR AN OPEN 48 First Episode Psychosis 48 Controlled Study 48 ECTRIMS 48 NO# [002] 48 Stacy Tessler Lindau 48 Tumor Microenvironment 48 Genetic Basis 48 CROI 48 Memory Study WHIMS 48 Prognostic Value 48 Patient Populations 48 Antiretroviral Therapy 48 Skin Lesions 48 Neurotoxicity 48 Renal Registry 48 Home Buyer Seller 48 clinicopathologic 48 Statin therapy 48 Postmarketing 48 Val HeFT 48 Subgroup analyzes 48 icatibant 48 Genitourinary Cancers Symposium 48 Substance Use 48 Diagnostic Criteria 48 Cancer Biomarkers 48 Longitudinal studies 48 Quantitative Impact 48 Clinical Efficacy 48 Randomized Controlled Trial 48 Atherosclerosis Risk 48 Psychosomatic Research 48 trials RCTs 48 placebo controlled randomized 48 controlled multicenter 48 prospectively randomized 48 Thromboembolic 48 Male Fertility 48 subgroup analyzes 48 NATRECOR R 48 Acute Ischemic Stroke 48 Histologic 48 Coronary Artery Bypass Graft 48 ASPIRE HIGHER 48 Urodynamics 48 SYNTAX 48 Cognitive Aging 48 prospectively defined 48 Chemotherapeutic Agents 48 multicenter Phase II 47 ARIXTRA 47 Dialysis Outcomes 47 ENDEAVOR IV 47 Pulmonary Arterial Hypertension 47 Pharmacogenetic 47 Vertebral Fracture 47 canakinumab 47 Heritability 47 Chronic Lymphocytic Leukemia 47 Degarelix 47 extracellular dopamine 47 Subtypes 47 Child Wellbeing 47 Epidemiologic studies 47 reboxetine 47 Insulin Therapy 47 Sipuleucel T 47 Schizophrenia Treatment 47 Cervical Cancer Screening 47 Reproductive Toxicology 47 Phase III placebo controlled 47 Breast Cancer Stem Cells 47 knee OA 47 Neoadjuvant 47 SEER database 47 Hepatocellular Carcinoma HCC 47 ACOSOG Z# 47 HOPE TOO 47 tarenflurbil 47 Molecular Epidemiology 47 Antiviral Therapy 47 angiographically 47 Fracture Intervention Trial 47 prospective randomized controlled 47 coronary calcification 47 PIX# [002] 47 Recurrent Stroke 47 multicenter clinical 47 Vascular Disease 47 Ionizing Radiation 47 Munk Olsen 47 Heart Failure Patients 47 randomized controlled trial 47 Tocilizumab 47 British Gambling Prevalence 47 multicenter multinational 47 Interstitial Cystitis 47 exploratory endpoints 47 Framingham Offspring 47 ENGAGE AF TIMI 47 Localized Prostate Cancer 47 Epidemiological Study 47 malignant neoplasms 47 fosbretabulin 47 HGPIN 47 Iron Overload 47 Genetics Consortium 47 Interpersonal Violence 47 BRIM2 47 Toxicological 47 Car Naturalistic Driving 47 Breast Cancer Metastasis 47 Hospitalized Patients 47 Oncologic 47 virologic failures 47 journal Cephalalgia 47 TAXUS ARRIVE 47 Rosuvastatin 47 Radiation Induced 47 randomized multicenter trial 47 Pregnancy Registry 47 Investigational Drug 47 prospective multicenter randomized 47 ACOMPLIA R 47 Depressive Symptoms 47 ASCO GI 47 dbGaP 47 Pelvic Pain 47 Epidemiologic Catchment Area 47 inhibitor RG# 47 Pharmacotherapy 47 multicenter 47 Anxiety Depression 47 journal Diabetologia 47 Epilepsy Surgery 47 Neuroprotective Effects 47 Molecular Psychiatry 47 Calcium Intake 47 Renal Cancer 47 Thrombophilia 47 Histological 47 Multiple logistic regression 47 susceptibility locus 47 Mortality Weekly 47 number NCT# ClinicalTrials.gov 47 Cardiometabolic Risk 47 Thrombotic 47 Adjuvant Chemotherapy 47 Cancer Registries 47 Menopausal Women 47 Stephan Herzig 47 venous thromboembolic disease 47 randomized clinical 47 study1 47 Postmenopausal Women 47 Morbid Obesity 47 Assessment Questionnaire 47 Diabetic Medicine 47 Outcome Measures 47 Suicidality 47 Observational studies 47 BMC Psychiatry 47 Correlates 47 hyperhomocysteinemia 47 Epidemiological 47 Neoadjuvant Chemotherapy 47 Epilepsia 47 acute myocardial infarction MI 47 Pre RELAX AHF 47 Birth Defect 47 ALTTO 47 Interpersonal psychotherapy 47 tibolone 47 Cancer Stem Cells 47 ADAGIO study 47 Nutrition EPIC 47 Adenoma 47 Debit Issuer 47 Ambulatory Pediatrics 47 J Virol 47 Coronary Artery Disease 47 Prolongs Survival 47 Histopathological 47 Colorectal Screening 47 Phase III randomized controlled 47 BEIR 47 neuropathologic 47 journal Urology 47 HPV Vaccination 47 registrational Phase 47 Study HERS 47 Prevent Child 47 Juvenile Idiopathic Arthritis 47 JD Power Vehicle Dependability 47 neuropsychiatric symptoms 47 APTIVUS 47 journal Molecular Psychiatry 47 Atorvastatin Evaluation 47 Targeted Therapy 47 Genetic Susceptibility 47 Prostate Cancer Risk 47 Practice Patterns 47 KIF6 gene variant 47 Cancer Incidence Mortality 46 Attack Trial ALLHAT 46 metachronous 46 Myocardial Infarction Study 46 Hepatitis C Virus 46 SPIRIT III 46 adenoma recurrence 46 multiple logistic regression 46 Phase Ib Clinical Trial 46 Laryngeal Cancer 46 Prostrate Cancer 46 #-# Full Text 46 Breast Cancer Risk 46 BMC Musculoskeletal Disorders 46 Long Term Outcomes 46 recurrent glioblastoma multiforme 46 Solid Tumors 46 Gender Differences 46 Menstrual Cycle 46 journal Lancet Neurology 46 pharmacoeconomic analysis 46 Acute Heart Failure 46 PECARN 46 MOTIVATE 46 Vulnerable Plaque 46 MMR Vaccine 46 atherosclerotic renal artery stenosis 46 Postnatal Depression 46 Patency 46 multivariate analyzes 46 Multiethnic Cohort Study 46 Uterine Fibroids 46 Heart Failure Trial 46 Coronary Prevention 46 Bivalirudin 46 APPRAISE 46 #:#-# [019] 46 REGARDS 46 Communities ARIC study 46 Determinants 46 postmenopausal osteoporotic women 46 Eye Disease 46 prostate cancer PCa 46 Replication NCS R 46 Gastrointestinal Oncology 46 Birth Registry 46 Phase III VISTA 46 Elocalcitol 46 GOUT 46 noscapine 46 Chronic Pelvic Pain 46 Cardiac Resynchronization 46 Hepatitis C Infection 46 pharmacokinetic PK 46 Cardiovascular Events 46 recurrent malignant glioma 46 Dr. Beilharz 46 CHAMPION PLATFORM 46 Longitudinal Studies 46 PERISCOPE 46 Demonstrates Efficacy 46 nonrandomized studies 46 Randomized trials 46 DCCT 46 periprocedural MI 46 Circulation Heart Failure 46 Renal Disease 46 ToGA 46 DRB1 * 46 beta carotene supplementation 46 LITHE 46 randomized controlled clinical trials 46 CYPHER Stent 46 Health Initiative WHI 46 Prostate Cancer 46 ALISTA 46 Meta Analyses 46 phase IIa clinical 46 Therapy Evaluation 46 NHANES III 46 urothelial cancer 46 Rakai Uganda 46 Molecular Genetic 46 testicular germ cell 46 Breast Cancer Survival 46 premenopausal women 46 Slone Epidemiology Center 46 COMT genotype 46 SIMPADICO 46 ImmuKnow assay 46 Lung Cancers 46 Venous Thrombosis 46 PLCO trial 46 Clinical Trial Results 46 Percutaneous Tibial Nerve Stimulation 46 journal Hepatology 46 Raloxifene Evaluation MORE 46 Enzastaurin 46 Lung Cancer Trial 46 OLYMPIA registry 46 adjuvant endocrine therapy 46 methodologic 46 HORIZONS AMI 46 Clinical Infectious Disease 46 NCI Cancer 46 Sorafenib HCC Assessment 46 Anticoagulation 46 Therapeutic Targets 46 Pulmonary Hypertension 46 Metastatic Prostate Cancer 46 Prostate Screening 46 TARGIT 46 ID NCT# 46 Chronic Diseases 46 EINSTEIN DVT 46 AJPH 46 Neurocognitive 46 Childhood Diseases 46 prucalopride 46 Psychiatric Epidemiology 46 Premature Ejaculation 46 Marrow Transplant 46 clinico pathological 46 ASM Biodefense 46 Prostate Cancer Survival 46 antioxidant supplementation 46 Individualized Treatment 46 Prevent Stroke 46 Iron Deficiency 46 TAXUS ATLAS 46 Pharmacokinetic 46 INTERPHONE study 46 phase IIa 46 blind randomized controlled 46 gene polymorphism 46 Neurological Diseases 46 Screening Questionnaire 46 CombAT 46 J Nutr 46 Blood Cancers 46 Renal Cell Carcinoma 46 journal Transfusion 46 Prostate Cancers 46 randomized Phase 2b 46 Phase III multicenter 46 p# biomarker 46 CIMZIA TM certolizumab pegol 46 Neck Cancer 46 multivariate logistic regression 46 Circulation Cardiovascular Quality 46 TAXUS IV 46 Prehypertension 46 recurrent VTE 46 Endovascular Valve Edge 46 Antiplatelet Therapy 46 Preclinical Study 46 familial aggregation 46 journal Appetite 46 Acquired Immune Deficiency Syndromes 46 Racial Differences 46 journal Biological Psychiatry 46 undergoing radical prostatectomy 46 Pre Eclampsia 46 Multiple Myeloma Patients 46 EMPHASIS HF trial 46 recurrent venous thromboembolism 46 COPAXONE R 46 diabetes mellitus DM 46 Clinical Trial Data 46 CARDIA study 46 Comorbidity Study 46 T2D 46 Psoriatic Arthritis 46 Colorectal Cancer Screening 46 thorough QT 46 Mood Disorder 46 thrombophilia 46 prostate cancer CRPC 46 Chronic Myeloid Leukemia 46 Group RTOG 46 MADIT CRT trial 46 Sustained Efficacy 46 glatiramer acetate 46 claudication 45 Survival Rates 45 colorectal cancer CRC 45 Osteoarthritis Patients 45 Predisposition 45 Lancet Oncology 45 BRCA2 mutation carriers 45 genetic polymorphisms 45 Cohort Study MACS 45 TQT 45 Phase IIIb study 45 Visual Perception 45 Breast Cancer Incidence 45 randomized multicenter Phase III 45 Screening Mammography 45 atherothrombotic 45 Pancreas Cancer 45 ICON7 45 Emerging Therapies 45 lignan intake 45 KRAS gene mutations 45 DMIST 45 invasive candidiasis 45 Hormone Refractory Prostate Cancer 45 CVD mortality 45 cytoreductive nephrectomy 45 Organ Failure 45 Stroke Risk 45 estrogen progestin therapy 45 Prevent Heart 45 double blinded placebo 45 Metabolic Efficiency 45 oral FTY# 45 relapsed MM 45 Electroencephalography 45 SWiTCH 45 Feasibility Trial 45 pancreatic ductal adenocarcinoma 45 Randomized Trial 45 Arterial Disease 45 DAPT Study 45 Unsafe Abortion 45 Breast Cancer Mortality